Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Audrey Zhi advises companies on regulatory, compliance, and investigation matters (particularly China-related anti-corruption matters). Ms. Zhi also has experience in advising multinational companies on corporate matters and transactions, including mergers and acquisitions, foreign direct investments, outbound investments, and employment. Her work focuses on the life science industry, including pharmaceuticals, medical device, cosmetics, and food.

  • Advised a world-leading gene sequencing company on the latest Chinese regulations and policies in a variety of fields, including precision medicine initiatives, non-intrusive prenatal testing, new-born screening, and laboratory development testing.
  • Assisted multinational pharmaceutical, healthcare, food and cosmetics companies on Chinese regulatory and compliance matters, such as preparing a white paper on microbiome products, monthly and quarterly reports, conducting regulatory and compliance due diligence, providing advice on genetic testing to detect cancers, companion diagnostics, cross-border e-commerce, used medical device, food contact materials, importation of raw meat product, donations to educational institutions, and preparing electronic alerts.
  • Assisted multinational pharmaceutical companies and the U.S. industrial association on strategic advice to initiate a new drug in China market, and providing implications for the American pharmaceutical drug industry due to China industry policy.
  • Assisted world-leading multinational companies across various industries (such as pharmaceuticals and medical devices, cosmetics, information technology, beverages, and investment bank) on anti-corruption and FCPA investigations, (including SEC China investigation), including due diligence, reviewing documents, preparing interview outlines, verifying regulatory approvals for previous transactions, and conducting interviews.
  • Advised a renowned multinational food processing and retail company on its sale of business.
  • Advised a global healthcare products company and manufacturer of medical devices and supplies on its restructuring.
  • Advised a global prestigious healthcare products company and manufacturer of medical devices and supplies on its spin-off of the pharmaceutical business.
  • Advised the world’s largest food, nutrition, health and wellness company on its acquisition of an existing Sino-foreign joint equity company from a state-owned Chinese party.
  • Assisted renowned multinational companies on their intra-group restructuring in multiple jurisdictions.
  • Advised one of the first internet payment services providers in Europe on its establishment of the first platform in China.
  • Advised on Chinese employment matters, including reviewing and commenting on employment contracts, confidentiality agreements and non-competition agreements, hiring of foreign employees in China, employment termination, and employment benefits arrangements (stock option and other incentive schemes).
  • Advised renowned multinational companies on mergers and acquisitions, foreign direct investment, outbound investment, regulatory and compliance matters, employment, general corporate matters, etc. in various industries relating to cosmetics, food and milk-products, medical devices and pharmaceuticals, entertainment, human resources, media, internet, drinking water, automotive manufacture, banking, insurance, wholesale and retail, fire-safety, general business consulting and others.

Pro Bono

  • Provided China legal services to the client (an international children's medical charity devoting itself to providing free surgeries for children and young adults suffering cleft lip, or other facial deformities, in more than 60 countries), including conducting legal research on the PRC laws and regulations regarding the operation of, and the compliance requirements applicable to, a foreign non-profit organization.
  • In support of the asylum application by the client (an LGBT man) in the United States, conducted research and prepared a memorandum on country conditions in the client’s home country, including, but not limited to, the legal, social cultural, and political environment.
  • Pennsylvania Law School, which is in partnership with the Pennsylvania Health Law Project, a 501(c)(3) legal service organization, under the supervision of U.S. attorneys, provided pro bono services to the local Philadelphia communities on health law.
  • A key member of Pro Bono Project, in the Shanghai office of a previous international law firm, providing legal advice on investments in China to, and the establishment of a micro-financing company in Inner Mongolia by, international nonprofit institutions.

Memberships and Affiliations

  • American Bar Association
  • New York State Bar Association
  • Fudan University Law School, admitted as ranking top 3% among all the applicants nationwide
  • Shanghai University School of International Business and Management, with Honors and with Distinction, Full Scholarship